Qingwei Luo
Overview
Explore the profile of Qingwei Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
1300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lew J, Luo Q, Worthington J, Ge H, He E, Steinberg J, et al.
Med Decis Making
. 2025 Feb;
:272989X251314050.
PMID: 39915917
Background: Changing colorectal cancer (CRC) incidence rates, including recent increases for people younger than 50 y, need to be considered in planning for future cancer control and screening initiatives. Reliable...
2.
Wade S, Ngo P, He Y, Caruana M, Steinberg J, Luo Q, et al.
Public Health Res Pract
. 2024 Dec;
PMID: 39694854
Australia's National Lung Cancer Screening Program will commence in July 2025, targeted at individuals aged 50-70 years with a 30 pack-year smoking history (equivalent to 20 cigarettes per day for...
3.
Luo Q, Chen X, Tang J, Yan W, Li Z
Discov Med
. 2024 Sep;
36(188):1800-1810.
PMID: 39327243
Background: Colon cancer (CC) is a highly prevalent malignancy that contributes significantly to global morbidity and mortality. The polycomb group ring finger 2 (PCGF2) has been identified as a relevant...
4.
Egger S, David M, Watts C, Dessaix A, Brooks A, Jenkinson E, et al.
Aust N Z J Public Health
. 2024 Sep;
48(5):100173.
PMID: 39261180
Objective: The objective of this study was to estimate the association between vaping and subsequent initiation of smoking among Australian adolescents and explore the impact of design and analytical methods...
5.
6.
Feletto E, Luo Q, Kelly A, Weber M, Goldsbury D, Barron K, et al.
Cancer Biol Med
. 2024 Jul;
21(8).
PMID: 39015009
Objective: Australia has relatively high multiple myeloma (MM) incidence and mortality rates. Advancements in MM treatment over recent decades have driven improvements in MM survival in high-income countries; however, reporting...
7.
Luo Q, Jenkin D, Weber M, Steinberg J, White K, Irving A, et al.
Med J Aust
. 2024 Jul;
221(2):103-110.
PMID: 39003689
Objectives: To examine changes in multiple myeloma incidence and mortality rates during 1982-2018, and to estimate its incidence, mortality, and prevalence for 2019-2043. Study Design: Population-based statistical modelling study; analysis...
8.
Yap S, Luo Q, Wade S, Ngo P, Goldsbury D, Sarich P, et al.
Cancer Epidemiol
. 2024 Apr;
90:102567.
PMID: 38603997
Background: Weighting can improve study estimate representativeness. We examined the impact of weighting on associations between participants' characteristics and cancer, cardiovascular and all-cause mortality in the Australian 45 and Up...
9.
Luo Q, Steinberg J, Kahn C, Caruana M, Grogan P, Page A, et al.
Lancet Reg Health West Pac
. 2024 Mar;
43:100987.
PMID: 38456088
Background: Long-term projections of premature mortality (defined as deaths age <75 years) help to inform decisions about public health priorities. This study aimed to project premature mortality rates in Australia...
10.
Caruana M, Gulati R, Etzioni R, Barratt A, Armstrong B, Chiam K, et al.
Int J Cancer
. 2023 Oct;
154(4):648-658.
PMID: 37819139
Guidelines for prostate specific antigen (PSA) testing in Australia recommend that men at average risk of prostate cancer who have been informed of the benefits and harms, and who decide...